| 发明名称 |
NOVEL AZOLE COMPOUND |
| 摘要 |
Azole compounds represented by formula I: wherein ring A is isoxazole and the like, R1 is a substituted or unsubstituted aryl group and the like, R2 is a hydrogen atom and the like, and R3 is a substituted or unsubstituted alkyl group and the like, and pharmaceutically acceptable salts thereof inhibit the physiological activity of lysophosphatidic acid (LPA), and are useful as for the prophylaxis or treatment of diseases in which inhibition of the physiological activity of LPA is useful for the prophylaxis or treatment thereof, such as diseases involving the LPA receptor.
|
| 申请公布号 |
US2013041000(A1) |
申请公布日期 |
2013.02.14 |
| 申请号 |
US201213585011 |
申请日期 |
2012.08.14 |
| 申请人 |
AJINOMOTO CO., INC.;YAMAMOTO TAKASHI;CHIBA AKIRA;FUJITA KOICHI;KATABA YUKA;OHSUMI KOJI;ASARI SAYAKA;FUKUCHI NAOYUKI;NOGUCHI MISATO;TANABE ITSUYA;IJICHI CHIORI;OOMUTA NAOKO;IIDA YUKO;IWAYAMA SATOSHI |
发明人 |
YAMAMOTO TAKASHI;CHIBA AKIRA;FUJITA KOICHI;KATABA YUKA;OHSUMI KOJI;ASARI SAYAKA;FUKUCHI NAOYUKI;NOGUCHI MISATO;TANABE ITSUYA;IJICHI CHIORI;OOMUTA NAOKO;IIDA YUKO;IWAYAMA SATOSHI |
| 分类号 |
A61K31/42;A61K31/422;A61K31/4245;A61K31/425;A61K31/433;A61P1/00;A61P1/16;A61P1/18;A61P5/48;A61P11/00;A61P13/02;A61P13/08;A61P13/12;A61P25/00;A61P25/02;A61P29/00;A61P35/00;A61P43/00;C07D261/14 |
主分类号 |
A61K31/42 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
